Search

Discover how Martina bounced back after a transnasal procedure to have a pituitary tumor removed at Memorial Sloan Kettering.

… Hear from Our Patients Martina's Story By Memorial Sloan Kettering Editorial Staff When Syracuse University student Martina learned she had a tumor at the base of her skull in 2016, she and her family sought out the Multidisciplinary Pituitary and Skull Base Tumor Center at Memorial Sloan Kettering.

… Job Title Research Fellow Degree MD Email [email protected] Lab Phone 646-888-3237

Watch and listen to a guided meditation led by MSK mind-body therapist Emily Herzlin.

… Watch and listen to a guided meditation led by MSK mind-body therapist Emily Herzlin.

… Job Title Director, Melanoma Clinic Dermatology, University of California, LA Education Rockefeller/Cornell/Sloan Kettering Degree MD, PhD Start Year 1997 End Year 2000 Email [email protected]

… Job Title Postdoctoral Fellow - currently: Associate Principal Scientist at AstraZeneca, Sweden The in vitro modeling of human disease via iPSC-technology has proven successful for numerous developmental and early-onset disorders. However, recreating the pathogenesis of age-dependent conditions such

An antibody test developed at MSK could shed light on the immune response to the COVID-19 virus.

… Tuesday, September 22, 2020 Summary A test developed by MSK researchers can detect three different antibodies to the COVID-19 virus. The test could help researchers clarify how someone fights off the virus, as well as who might be best protected if they are exposed a second time. Testing for antibodies

Blood pressure should be monitored closely and on an ongoing basis for several months after initiating ibrutinib treatment in patients with chronic lymphocytic leukemia (CLL), according to our retrospective study.

… Wednesday, January 8, 2020 Blood pressure should be monitored closely and on an ongoing basis for several months after initiating ibrutinib treatment in patients with chronic lymphocytic leukemia (CLL), according to our retrospective study published this month in JAMA Network Open . Hypertension is a

根据我们的回顾性研究，在慢性淋巴细胞白血病 (CLL) 患者开始接受伊鲁替尼治疗后，应密切监测其血压，并持续数月。

… Wednesday, January 8, 2020 根据我们本月发表在《美国医学会杂志网络公开》 (JAMA Network Open) 上的回顾性研究，在慢性淋巴细胞白血病 (CLL) 患者开始接受伊鲁替尼治疗后，应密切监测其血压，持续数月。 高血压是临床试验中接受伊鲁替尼治疗的 CLL 患者发生的常见不良事件。我们在非临床试验环境中研究了 CLL 患者中与伊鲁替尼相关的高血压的发展模式、管理策略和长期血管影响。  (1) 我们的结果显示，在接受伊鲁替尼治疗的 247 例 CLL 患者的整个队列中，包括存在和不存在高血压病史的患者，患者的血压均发生显著升高。 我们的结果显示，在接受伊鲁替尼治疗的

… Goals of PFACQ To integrate the patient, family, and caregiver perspective into every aspect of MSK’s efforts to prevent, diagnose, treat, and end cancer for life. For every patient, family member, and caregiver to experience state of the art cancer care that is safe, responsive, compassionate, efficient